Abstract
The relationship between human cytomegalovirus (HCMV) and glioblastoma (GBM) is an ongoing debate with extensive evidence supporting or refuting its existence through molecular assays, pre-clinical studies, and clinical trials. We focus primarily on the crux of the debate, detection of HCMV in GBM samples using molecular assays. We propose that these differences in detection could be affected by cellular heterogeneity. To take this into account, we align the single-cell RNA sequencing (scRNA-seq) reads from five GBM tumors and two cell lines to HCMV and analyze the alignments for evidence of (i) complete viral transcripts and (ii) low-abundance viral reads. We found that neither tumor nor cell line samples showed conclusive evidence of full HCMV viral transcripts. We also identified low-abundance reads aligned across all tumors, with two tumors having higher alignment rates than the rest of the tumor samples. This work is meant to rigorously test for HCMV RNA expression at a single cell level in GBM samples and examine the possible utility of single cell data in tumor virology.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amirian ES, Bondy ML, Mo Q, Bainbridge MN, Scheurer ME (2014) Presence of viral DNA in whole-genome sequencing of brain tumor tissues from the cancer genome atlas. J Virol 88(1):774. doi:10.1128/JVI.02725-13
Bacher R, Kendziorski C (2016) Design and computational analysis of single-cell RNA-sequencing experiments. Genome Biol 17:63. doi:10.1186/s13059-016-0927-y
Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A et al (2011) Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 121(10):4043–4055. doi:10.1172/JCI57147
Baumgarten P, Michaelis M, Rothweiler F, Starzetz T, Rabenau HF, Berger A et al (2014) Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics. Neuro-Oncology 16(11):1469–1477. doi:10.1093/neuonc/nou167
Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30(15):2114–2120. doi:10.1093/bioinformatics/btu170
Center, O. S (1987) Ohio Supercomputer Center. Ohio Supercomputer Center, Columbus OH
Cobbs C (2015) Reply to: towards an unbiased, collaborative effort to reach evidence about the presence of human cytomegalovirus in glioblastoma (and other tumors). Neuro-Oncology 17(7):1040. doi:10.1093/neuonc/nov077
Cosset E, Petty TJ, Dutoit V, Cordey S, Padioleau I, Otten-Hernandez P et al (2014) Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response. Int J Cancer 135(6):1381–1389. doi:10.1002/ijc.28670
Cunningham C, Gatherer D, Hilfrich B, Baluchova K, Dargan DJ, Thomson M et al (2010) Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol 91(Pt 3):605–615. doi:10.1099/vir.0.015891-0
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15–21. doi:10.1093/bioinformatics/bts635
Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ (2011) National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol 18(11):1895–1899. doi:10.1128/CVI.05228-11
dos Santos CJ, Stangherlin LM, Figueiredo EG, Correa C, Teixeira MJ, da Silva MC (2014) High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients. J Med Virol 86(11):1953–1961. doi:10.1002/jmv.23820
Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V et al (2003) Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100(24):14223–14228. doi:10.1073/pnas.2334032100
Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M et al (2012) Consensus on the role of human cytomegalovirus in glioblastoma. Neuro-Oncology 14(3):246–255. doi:10.1093/neuonc/nor227
Fleiss JL, Levin B, Paik MC (2003) Statistical methods for rates and proportions, 3rd edn. J. Wiley, Hoboken, N.J
Fornara O, Bartek J Jr, Rahbar A, Odeberg J, Khan Z, Peredo I et al (2016) Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact. Cell Death Differ 23(2):261–269. doi:10.1038/cdd.2015.91
Hadaczek P, Ozawa T, Soroceanu L, Yoshida Y, Matlaf L, Singer E et al (2013) Cidofovir: a novel antitumor agent for glioblastoma. Clin Cancer Res 19(23):6473–6483. doi:10.1158/1078-0432.CCR-13-1121
Hashida Y, Taniguchi A, Yawata T, Hosokawa S, Murakami M, Hiroi M et al (2015) Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects. Infect Agent Cancer 10:3. doi:10.1186/1750-9378-10-3
Holdhoff, M., Rodriguez, F., Hicks, J., Zheng, Q., Forman, M., Ye, X.,. .. Arav-Boger, R. (2015). ATPS-33 evidence of absence for cytomegalovirus in patients with glioblastomas and other high-grade gliomas by real-time pcr for dna, immunohistochemistry for protein and in-situ hybridization for mRNA. Neuro Oncol, 17(suppl_5)
Jenkins C, Abendroth A, Slobedman B (2004) A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 78(3):1440–1447
Joseph GP, McDermott R, Baryshnikova MA, Cobbs CS, Ulasov IV (2017) Cytomegalovirus as an oncomodulatory agent in the progression of glioma. Cancer Lett 384:79–85. doi:10.1016/j.canlet.2016.10.022
Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J et al (2013) Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 87(16):8916–8926. doi:10.1128/JVI.00340-13
Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S (2000) Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 97(4):1695–1700
Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, Salzberg SL (2004) Versatile and open software for comparing large genomes. Genome Biol 5(2):R12. doi:10.1186/gb-2004-5-2-r12
Lawler SE (2015) Cytomegalovirus and glioblastoma; controversies and opportunities. J Neuro-Oncol 123(3):465–471. doi:10.1007/s11060-015-1734-0
Lehrer S, Green S, Rosenzweig KE, Rendo A (2015) No circulating human cytomegalovirus in 14 cases of glioblastoma. Neuro-Oncology 17(2):320. doi:10.1093/neuonc/nou325
Libard S, Popova SN, Amini RM, Karja V, Pietilainen T, Hamalainen KM et al (2014) Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS One 9(9):e108861. doi:10.1371/journal.pone.0108861
Lister R, O'Malley RC, Tonti-Filippini J, Gregory BD, Berry CC, Millar AH, Ecker JR (2008) Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133(3):523–536. doi:10.1016/j.cell.2008.03.029
McFaline-Figueroa JR, Wen PY (2017) The viral connection to glioblastoma. Curr Infect Dis Rep 19(2):5. doi:10.1007/s11908-017-0563-z
Michaelis M, Doerr HW, Cinatl J (2009) The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11(1):1–9
Michaelis M, Mittelbronn M, Cinatl J Jr (2015) Towards an unbiased, collaborative effort to reach evidence about the presence of human cytomegalovirus in glioblastoma (and other tumors). Neuro-Oncology 17(7):1039. doi:10.1093/neuonc/nov048
Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5(7):621–628. doi:10.1038/nmeth.1226
Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, Gerstein M, Snyder M (2008) The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320(5881):1344–1349. doi:10.1126/science.1158441
Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396–1401. doi:10.1126/science.1254257
Patro R, Mount SM, Kingsford C (2014) Sailfish enables alignment-free isoform quantification from RNA-seq reads using lightweight algorithms. Nat Biotechnol 32(5):462–464. doi:10.1038/nbt.2862
Prins RM, Cloughesy TF, Liau LM (2008) Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 359(5):539–541. doi:10.1056/NEJMc0804818
Rahbar A, Stragliotto G, Orrego A, Peredo I, Taher C, Willems J, Soderberg-Naucler C (2012) Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival—a case-control study. Herpesviridae 3:3. doi:10.1186/2042-4280-3-3
Rossetto CC, Tarrant-Elorza M, Pari GS (2013) Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells. PLoS Pathog 9(5):e1003366. doi:10.1371/journal.ppat.1003366
Sardi I, Lucchesi M, Becciani S, Facchini L, Guidi M, Buccoliero AM et al (2015) Absence of human cytomegalovirus infection in childhood brain tumors. Am J Cancer Res 5(8):2476–2483
Schelhorn SE, Fischer M, Tolosi L, Altmuller J, Nurnberg P, Pfister H et al (2013) Sensitive detection of viral transcripts in human tumor transcriptomes. PLoS Comput Biol 9(10):e1003228. doi:10.1371/journal.pcbi.1003228
Scheurer ME, El-Zein R, Bondy ML, Harkins L, Cobbs CS (2007) RE: “lack of association of herpesviruses with brain tumors”. J Neuro-Oncol 13(1):85; author reply 86-87. doi:10.1080/13550280601164325
Shamran HA, Kadhim HS, Hussain AR, Kareem A, Taub DD, Price RL et al (2015) Detection of human cytomegalovirus in different histopathological types of glioma in Iraqi patients. Biomed Res Int 2015:642652. doi:10.1155/2015/642652
Soderberg-Naucler C, Johnsen JI (2015) Cytomegalovirus in human brain tumors: role in pathogenesis and potential treatment options. World J Exp Med 5(1):1–10. doi:10.5493/wjem.v5.i1.1
Soderberg-Naucler C, Rahbar A, Stragliotto G (2013) Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 369(10):985–986. doi:10.1056/NEJMc1302145
Solomon IH, Ramkissoon SH, Milner DA Jr, Folkerth RD (2014) Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment. J Neuropathol Exp Neurol 73(11):994–998. doi:10.1097/NEN.0000000000000125
Sottoriva A, Spiteri I, Piccirillo SG, Touloumis A, Collins VP, Marioni JC et al (2013) Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A 110(10):4009–4014. doi:10.1073/pnas.1219747110
Stangherlin LM, Castro FL, Medeiros RS, Guerra JM, Kimura LM, Shirata NK et al (2016) Human cytomegalovirus DNA quantification and gene expression in gliomas of different grades. PLoS One 11(7):e0159604. doi:10.1371/journal.pone.0159604
Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 43(9):1143–1151. doi:10.1086/508173
Strong MJ, Blanchard E t, Lin Z, Morris CA, Baddoo M, Taylor CM et al (2016) A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus—tumor association. Acta Neuropathol Commun 4(1):71. doi:10.1186/s40478-016-0338-z
Tang KW, Alaei-Mahabadi B, Samuelsson T, Lindh M, Larsson E (2013) The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat Commun 4:2513. doi:10.1038/ncomms3513
Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR et al (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7(3):562–578. doi:10.1038/nprot.2012.016
Van Damme E, Van Loock M (2014) Functional annotation of human cytomegalovirus gene products: an update. Front Microbiol 5:218. doi:10.3389/fmicb.2014.00218
Wick W, Platten M (2014) CMV infection and glioma, a highly controversial concept struggling in the clinical arena. Neuro-Oncology 16(3):332–333. doi:10.1093/neuonc/nou002
Wolmer-Solberg N, Baryawno N, Rahbar A, Fuchs D, Odeberg J, Taher C et al (2013) Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? Int J Cancer 133(10):2351–2361. doi:10.1002/ijc.28265
Wu AR, Neff NF, Kalisky T, Dalerba P, Treutlein B, Rothenberg ME et al (2014) Quantitative assessment of single-cell RNA-sequencing methods. Nat Methods 11(1):41–46. doi:10.1038/nmeth.2694
Wu L, Zhang X, Zhao Z, Wang L, Li B, Li G et al (2015) Full-length single-cell RNA-seq applied to a viral human cancer: applications to HPV expression and splicing analysis in HeLa S3 cells. Gigascience 4:51. doi:10.1186/s13742-015-0091-4
Acknowledgements
The authors acknowledge RGP0053 of the Human Frontier Science Program, National Library of Medicine Multi-Modeling and Integrative Data Analytics Training Program (T15LM011270-05), the Ohio Super Computer for computation resources and Yan Zhang acknowledges support from the Department of Biomedical Informatics at The Ohio State University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(DOCX 2667 kb)
Rights and permissions
About this article
Cite this article
Johnson, T.S., Abrams, Z.B., Mo, X. et al. Lack of human cytomegalovirus expression in single cells from glioblastoma tumors and cell lines. J. Neurovirol. 23, 671–678 (2017). https://doi.org/10.1007/s13365-017-0543-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-017-0543-y